Showing posts with label schizophrenia. Show all posts
Showing posts with label schizophrenia. Show all posts

Monday, January 31, 2011

Understanding Psychosis

By  Sara Coffey, D.O.



Often patients and family members have a hard time understanding how a person can be psychotic.  Psychosis is defined as grossly impaired reality testing. Psychosis can be present in several mental illnesses including, schizophrenia, schizoaffective disorder, bipolar disorder and even depression.

The stigma or lack of information surrounding these disorders leaves them feeling guilty or ashamed. I often explain to them that the brain is an organ just like the heart, the kidneys or the liver. And just as our heart, kidneys or liver can become diseased, so can our brain.
The brain is a complicated organ with several different functions. It helps regulate our breathing, our heart rate, and our temperature and handles more complex tasks such as vision and hearing, pain sensations as well as processing complex thoughts or emotions. It is easy for us to understand that if the heart becomes damaged it might not pump as effectively, but it is often harder for us to understand what happens if the brain becomes compromised or unwell. A brain with mental illness may start to hear things that are not there, or experience thoughts that cannot be explained and seem irrational.  A person may become excessively anxious for no reason, or depressed without warning or cause.
In the world of mental illness we use terms to describe such experiences like hallucinations and delusions.  A patient with hallucinations might experience voices talking to them when no one is present. When we recall that one function of the brain is to process and interpret sound it is easy to see how auditory hallucinations might occur if that part of the brain is compromised.
Patients can have delusions that people are out to harm them for no reason, and without proof, or delusions that they are famous powerful figures in history. And again, when we look at how the mind works, how complex processes are taking place that help us navigate who we are and what we do, it makes sense that if something wasn’t working normally in the brain that a person could have a belief that was false.
Although these symptoms might make sense when we look at the brain as an organ, or a tool performing a function, it doesn’t lessen the impact mental illness has on families. Often mental illness takes away what we consider the heart or personality of person and this can be extremely difficult to cope with. Furthermore, the simplicity of understanding is not without criticism. For instance although we are learning more and more about the brain every day, there is still no cure for mental illness, only treatment for symptoms, and often times the treatment cannot fully clear the symptoms of certain diseases.
However, it is important to know that psychosis, like other mental illness symptoms, is not the fault of the person with the illness or the family who cares for them. These symptoms are part of a complex illness that affects patients unwillingly every day.


Sunday, January 16, 2011

Where are the Niacin Studies for Schizophrenia?

from November 2009, timely today in regard to the discussion about psychiatry currently in the news.

UPDATE 12/21 - Food Sources of Niacin (B3)

UPDATE: 12/18 - If you have been a proponent of natural mental health you would already have known that omega 3 EFAs have been an effective help to many who live with several mental health issues.
BETHESDA, Md., Dec. 18 (UPI) -- Deficiencies in omega-3 fatty acids may be a factor in mental illnesses, U.S. researchers suggest.

The study, published in Behavioral Neuroscience, named two omega-3 fatty acids -- docosahexaenoic acid and eicosapentaenoic acid -- as key to maintaining a nervous system capable of avoiding sensory overload.

The researchers suggest low omega-3 may be linked to the information-processing problems found in people with afflictions of the nervous system including schizophrenia and bipolar, obsessive-compulsive, attention-deficit hyperactivity disorders.

The researchers looked at nervous system function in the offspring of four groups of pregnant mice that had been fed different diets with no or varying types and amounts of omega-3s. Only the mice raised on the two omega-3 fatty acids showed normal, adaptive sensorimotor nervous responses that did not result in the animals being perpetually startled and easily overwhelmed by sensory stimuli.

"It is an uphill battle now to reverse the message that 'fats are bad,' and to increase omega-3 fats in our diet," study leader Norman Salem Jr. of the National Institute on Alcohol Abuse and Alcoholism in Bethesda said in a statement.
-----------------------------------------------------
Travelling back some 50 or more years ago there were some members of the medical profession who took a totally different look at mental health issues.  Instead of fluoride based anti-psychotics, these courageous fellows relied on nutritional supplementation and effectively treated thousands of people diagnosed as schizophrenic.

And to make it all the more respectable, numerous scientific reports were issued on this care that came to be known as orthomolecular medicine.

And you might wonder why PubMed fails to include the orthomolecular journal so you might be more able to find related data.

Schizophrenia and Schizoaffective Disorders
Double blind controlled therapeutic trials in Saskatchewan in 1952 showed that adding vitamin B-3 to the treatment then available, which was electro convulsive therapy, doubled the recovery rate. From this start, and corroborated by a large number of clinical studies and by one double blind corroborative study that was sponsored by National Institute of Mental Health, Washington, this early treatment has been refined and expanded. There are no negative studies. It now includes examination of the diet for possible food allergies; includes using optimum doses of vitamin B-3, which range from 3 to 12 or more grams daily; includes the use of vitamin C as an important antioxidant and other vitamins if needed, plus the best medication. As patients respond, the doses of medication and the nutrients are adjusted until the optimum doses of all nutrients and drugs is achieved. This treatment should be under medical control.

Nutrients Most Commonly Used For Schizophrenia and Schizo-Affective Disorders (under medical supervision):



* Vitamin B-3

* Vitamin C

* Vitamin B-6

* Zinc

* Vitamin B complex

* Selenium

Mood Disorders: Anxiety, Bipolar or Depression -
The following nutrients are helpful in controlling mood disorders (under medical supervision):


* Niacinamide

* B complex

* Vitamin C

* Folic acid

* Vitamin D

* Vitamin B-6
* Zinc citrate

* Essential fatty acids


In contrast to anti depressant medication I have not yet seen the type of warning issued by Professor Lana Watkins PhD, Duke University, who told the Annual meeting of the American Psychosomatic Society held in Denver, March 4, 2006, that current anti depressants increased the risk of dying from heart disease by 55 percent.

"Orthomolecular treatment does not lend itself to rapid drug-like control of symptoms, but patients get well to a degree not seen by tranquilizer therapists who believe orthomolecular therapists are prone to exaggeration. Those who've seen the results are astonished." 
---Abram Hoffer, M.D., Ph.D., 1917-2009

Read: http://naturalhealthnews.blogspot.com/2009/08/arthritis-drugs-pose-cancer-risk.html

FDA Okays New Antipsychotic for Schizophrenia, Bipolar Disorder
By Cole Petrochko, Staff Writer, MedPage Today, August 14, 2009
WASHINGTON -- The FDA approved the atypical antipsychotic asenapine (Saphris) for schizophrenia and bipolar disorder in adults, making it the first psychotropic drug to gain initial approval for both conditions.

The drug is indicated for first-line use in acute treatment of schizophrenia and of manic or mixed episodes in bipolar I disorder, with or without psychotic features.

FDA approval was based on data from more than 3,000 patients showing statistically significant efficacy versus placebo in acute schizophrenia trials and statistically significant reduction of bipolar mania symptoms versus placebo.

The drug showed signs of treating negative schizophrenia symptoms better than risperidone (Risperdal) in early clinical trials, but the advantage was not subsequently confirmed against olanzapine (Zyprexa, Zydis). (See APA: New Drug No Better for Negative Schizophrenia Symptoms)

Like other atypical antipsychotics, asenapine's side effects include sedation, weight gain, tardive dyskinesia, and diabetes risks. However, a clinical trial showed that asenapine's rate of weight gain was significantly lower than that experienced with olanzapine, a similar antipsychotic.

Atypical antipsychotics also show an increased likelihood of death in elderly patients treated for dementia-related psychosis.

The tablets are available in five and 10 mg doses and should be taken twice daily.

Manufacturer Schering-Plough said it plans to make the drug available in the fourth quarter of 2009.

Monday, June 7, 2010

Haldol and your shrinking brain

Drug for schizophrenia causes side effects by shrinking part of the brain.

My comments: Just think of the number of people diagnosed with Alzheimer's being prescribed Haldol, a fluoride-based anti-psychotic, and the reports associating brain shrinkage with the diagnosis.
Additionally, the severe side effect from Haldol is known as Tardive Dyskinesia, with symptoms noted in italics below. (One nautral treatment for TD is the use of organic and properly prepared valerian root extract.)


by Amy Maxmen

A commonly-prescribed antipsychotic drug shrinks the brain within hours of administration.

A leading antipsychotic drug temporarily reduces the size of a brain region that controls movement and coordination, causing distressing side effects such as shaking, drooling and restless leg syndrome.

Just two hours after injection with haloperidol, an antipsychotic commonly prescribed to treat schizophrenia, healthy volunteers experienced impaired motor abilities that coincided with diminished grey-matter volume in the striatum1 — a brain region that mediates movement.

"We've seen changes in the brain before, but to see significant remodelling of the striatum within a couple of hours is staggering," says Clare Parish at the Howard Florey Institute for brain research in Melbourne, Australia, who was not involved in the study.

complete article continues here

Monday, May 10, 2010

Talking about Mental Health

By R. Scott Benson, M.D.





In May a few years ago I was asked to give a talk to the seniors who exercised at the mall in the early morning hours. The timing was right for a mental health talk, since May is Mental Health Month.



The focus of my talk was new understanding of the brain and changing thoughts on the cause and treatment of mental illness. The audience was attentive but asked few questions. But after the talk an elderly man approached to clarify some comments I had made about schizophrenia. He called his wife over and they shared the painful story of their adult son’s deterioration as he developed unmistakable signs of this tragic disease.



This couple had been told by the treatment team that their parenting had caused their son’s condition and they needed to leave him alone so that he could recover. And they had carried a burden of guilt for years, viewing themselves as somehow toxic. I was able to answer a few of their questions and then I was encouraged them to join other families involved with our local chapters of Mental Health America and the National Alliance on Mental Illness.



The positive impact of these brave families sharing their stories was reinforced in a new survey from the American Psychiatric Association. And the results of this survey are a cause for celebration telling us how far we have come. More than a third said that stigma has declined, and openness about personal experiences by friends, family and public figures was influential.



The internet has become a valued source of information and was cited by 75% of those surveyed as at least moderately influential in reducing stigma associated with mental illness.



In addition to HealthyMinds, what are the reliable sources of information that have been useful to you? Where have you heard patient and family stories that have reduced stigma in your community?

Thursday, April 29, 2010

Death Effects and Schizophrenia Drugs

MEDLINE Abstract

--------------------------------------------------------------------------------
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Lancet. 2009; 374(9690):620-7 (ISSN: 1474-547X)
Tiihonen J ; Lönnqvist J ; Wahlbeck K ; Klaukka T ; Niskanen L ; Tanskanen A ; Haukka J
Department of Forensic Psychiatry, University of Kuopio and Niuvanniemi Hospital, Department of Clinical Physiology, Kuopio University Hospital, Kuopio, Finland. jari.tiihonen@niuva.fi

BACKGROUND: The introduction of second-generation antipsychotic drugs during the 1990s is widely believed to have adversely affected mortality of patients with schizophrenia. Our aim was to establish the long-term contribution of antipsychotic drugs to mortality in such patients. METHODS: Nationwide registers in Finland were used to compare the cause-specific mortality in 66 881 patients versus the total population (5.2 million) between 1996, and 2006, and to link these data with the use of antipsychotic drugs. We measured the all-cause mortality of patients with schizophrenia in outpatient care during current and cumulative exposure to any antipsychotic drug versus no use of these drugs, and exposure to the six most frequently used antipsychotic drugs compared with perphenazine use. FINDINGS: Although the proportional use of second-generation antipsychotic drugs rose from 13% to 64% during follow-up, the gap in life expectancy between patients with schizophrenia and the general population did not widen between 1996 (25 years), and 2006 (22.5 years). Compared with current use of perphenazine, the highest risk for overall mortality was recorded for quetiapine (adjusted hazard ratio [HR] 1.41, 95% CI 1.09-1.82), and the lowest risk for clozapine (0.74, 0.60-0.91; p=0.0045 for the difference between clozapine vs perphenazine, and p<0.0001 for all other antipsychotic drugs). Long-term cumulative exposure (7-11 years) to any antipsychotic treatment was associated with lower mortality than was no drug use (0.81, 0.77-0.84). In patients with one or more filled prescription for an antipsychotic drug, an inverse relation between mortality and duration of cumulative use was noted (HR for trend per exposure year 0.991; 0.985-0.997). INTERPRETATION: Long-term treatment with antipsychotic drugs is associated with lower mortality compared with no antipsychotic use. Second-generation drugs are a highly heterogeneous group, and clozapine seems to be associated with a substantially lower mortality than any other antipsychotics. Restrictions on the use of clozapine should be reassessed. FUNDING: Annual EVO Financing (Special government subsidies from the Ministry of Health and Welfare, Finland).

PreMedline Identifier:19595447

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Monday, December 7, 2009

Another Oprah Faux Pas

UPDATE:  Not Surprising to NHN
No Free Speech for Oprah: A woman who tried to get her story told on the Oprah Winfrey show was told that they could not air her story because they were supported by the pharmacuetical companies. So here is Oprah Winfrey, one of the most influential, wealthy personalities on the planet controlled by the pharmaceutical companies.

UPDATE: Thank you to Shari Roan of the LA Times for kindly responding to my note to her about this situation.

********************************************
I continue to be amazed at the failure of Oprah Winfrey and her staff. 

With all of the alleged talent and money available at Harpo Productions one just might think the producers and Oprah just might open up their minds to reach out-of-the-box on "schizophrenia", especially when it comes to drugging children.

Jenny and her parents featured on today's Oprah discuss their situation as how it relates to this very young child taking lithium and clozaril for her condition.

At no time is there even a minuscule mention of natural treatment that is proven in schizophrenia.

The problem for the parents is they probably do not even know that Valencia CA is close to the office of the Safe Harbor Project.

Psychiatric Drug Side Effects Search Engine

And please also refer to Orthomolecular Medicine and especially the work of Abrahm Hoffer, MD.

You may also refer to this website
"Mental Health Care should be held to the ethical creed, "First, Do No Harm" and should be driven by positive patient outcomes, not profit. Psychiatric drugs pose very real health risks including psychosis, worsening depression, diabetes, stroke and sudden death. 
There are non-harmful medical solutions that do not require stigmatizing psychiatric labels and dangerous drugs."  Hyla Cass, MD
Neuroliminal Training

Shari Roan

Even Jenny's parents are taking antidepressants!  Michael and Susan

It does not have to be like this.  There is real non-drug help for this family.

And on a related and well known issue, as psychiatric drug reimbursement under Medicaid has been called to task, Poor Children Likelier to Get Antipsychotics.

Tuesday, October 6, 2009

O, Oprah

Oprah again had a real opportunity to make a difference in the lives of the children, their parents and the families interviewed on her program today, but she looked the other way.

Not far from Chicago is an excellent researcher who heads an organization that over the years has helped many children, adults and families with many forms of mental illness, including schizophrenia.

At no time during the Oprah show today did this organization get even the slightest mention, nor did Oprah offer any options to these families or her listeners that have clinically established over 50 years ago that schizophrenia is a brain allergy syndrome.

Of course mainstream medicine treats this as a DSM billable situation, even though for many decades psychiatrists have admitted they do not know what schizophrenia.

Now there is also the consideration that there are no new drugs for schizophrenia that are actually approved for use in children, and many of these drugs that are used carry serous black box warnings.

Wouldn't it be a wonderful world when we could turn on the Oprah show and see her discussing the known ways that resolve schizophrenia?

If we are to get real health reform, then this may be one of the best places to start.

Friday, June 12, 2009

Flu, Pregnancy and Schizophrenia

If one understands that a vaccine raises the risk you will contract the disease in the vaccine, putting pregnant women and their progeny at risk is unconscionable.

CDC Flu TARGET Group Guidelines for H1N1

Looking at the terrible state of mental health care today and the damge wrought by dangerous drugs used even more so makes a thinking person wonder what experiment will be next.

Flu During Pregnancy May Increase Risk Of Schizophrenia In Certain Offspring

ScienceDaily (2009-06-11) -- When mothers become infected with influenza during their pregnancy, it may increase the risk for schizophrenia in their offspring. Influenza is a very common virus and so there has been substantial concern about this association. A new study suggests that the observed association depends upon a pre-existing vulnerability in the fetus. ... > read full article



Make sure to read "Vitamin C Facts" for natural approaches to schizophrenia, Flu and Autism

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Macys Printable Coupons